Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-α and ribavirin treatment for chronic hepatitis C virus infection

Human Immunology

Volumn 64, Issue 5, 2003, Pages 497-504

  Sreenarasimhaiah, Jayaprakash ^a   Jaramillo, Andrés ^a   Crippin, Jeffrey ^a   Lisker Melman, Mauricio ^a   Chapman, William C ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD4+ T cells; CD8+ T cells; Hepatitis C virus; IFN ribavirin therapy

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; VIRUS ANTIGEN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; TREATMENT OUTCOME; VIRUS CORE;

EID: 0242515870     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(03)00041-7     Document Type: Article

References (33)

1. Heintges T, Wands J: HCV: epidemiology and transmission. Hepatology 26:521, 1997.
2. Di Bisceglie AM: Hepatitis C. Lancet 351:351, 1998.
3. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Flaccadori F, Ferrari C: Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the antiviral cell-mediated immune response. J Clin Invest 98: 706, 1996.
4. Pape GR, Gerlach TJ, Diepolder HM, Gruner N, Jung M, Santantonio T: Role of the specific T cell response for clearance and control of hepatitis C virus. J Viral Hepatol 6:36, 1999.
5. Lechner F, Wong SK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD: Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499, 2000.
6. Harcourt G, Hellier S, Bunce M, Satsangi J, Collier J, Chapman R, Phillips R, Klenerman P: Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J Viral Hepatol 8:174, 2001.
7. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 30:2479, 2000.
8. + T cell response in acute hepatitis C. Gastroenterology 117:933, 1999.
9. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC: Detection of type-2-like T helper cells in hepatitis C virus infection: implication for hepatitis C virus chronicity. Hepatology 25:449, 1997.
10. Hoofnagle JH, Di Bisceglie AM: The treatment of chronic viral hepatitis. N Engl J Med 336:347, 1997.
11. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J: Randomized trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 352:1426, 1998.
12. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling M-H, Cort S, Albrecht JK: Interferon alpha2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 339:1485, 1998.
13. + T cells. J Exp Med 178:1655, 1993.
14. Peters M: Actions of cytokines on the immune response and viral interactions: an overview. Hepatology 23:909, 1996.
15. Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, Cebon J: Type 1 IFNs enhance the terminal differentiation of dendritic cells. J Immunol 161:1947, 1998.
16. Cramp ME, Rossel S, Chokshi S, Carucci P, Williams R, Naoumov NV: Hepatitis C virus-specific T cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118:346, 2000.
17. Tam RC, Pai B, Bard J, Lim C, Averett DR, Phan UT, Milovanovic T: Ribavirin polarizes human T cell responses towards a type 1 cytokine profile. J Hepatol 30:376, 1999.
18. Dusheiko G, Main J, Thomas H, Reichard O, Lee C, Dhillon A, Rassam S, Fryden A, Reesink H, Bassendine M, Norkrans G, Cuypers T, Lelie N, Telfer P, Watson J, Weegink C, Sillikens P, Weiland O: Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol 25:591, 1996.
19. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM: Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and post-treatment with IFN-α. Hepatology 24:6, 1996.
20. Lohr HF, Gerken G, Roth M, Weyer S, Schlaak JF, Buschenfelde KM: The cellular immune responses induced in the follow-up of interferon-α treated patients with chronic hepatitis C may determine the therapy outcome. J Hepatol 29:524, 1998.
21. Lohr HF, Schmitz D, Arenz M, Weyer S, Gerken G, Buschenfelde KM: The viral clearance in IFN-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies. J Hepatol 31:407, 1999.
22. Barnes E, Harcourt G, Brown D, Lucas M, Phillips R, Dusheiko G, Klenerman P: The dynamics of T lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36:743, 2002.
23. Rehermann B, Chang K, McHutchison JG, Kokka R, Houghton M, Chisari FV: Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 98:1432, 1996.
24. Chang K, Gruener NH, Southwood S, Sidney J, Pape G, Chisari FV: Identification of HLA-A3 and B7 restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J Immunol 162:1156, 1999.
25. Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman W, Mohanakumar T: Lack of optimal T cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis. Hum Immunol 63:224, 2003.
26. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R: Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188:2205, 1998.
27. + T lymphocytes after infection with hepatitis C virus. J Virol 75:5550, 2001.
28. + T cells in peripheral blood. Viral Immunol 14:59, 2001.
29. + T cell responses in chronically infected and non-viremic patients. Eur J Immunol 31:1438, 2001.
30. Eckels DD, Wang H, Bian TH, Tabatabai N, Gill JC: Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection. Immunol Rev 174:90, 2000.
31. Paul W, Seder R: Lymphocyte responses and cytokines. Cell 76:2411994.
32. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM: B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3:944, 2002.
33. Foey A, Green P, Foxwell B, Feldmann M, Brennan F: Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritis. Arthritis Res 4:64, 2002.